Inter Parfums (IPAR)
(Delayed Data from NSDQ)
$125.66 USD
+3.12 (2.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.51 -0.15 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.66 USD
+3.12 (2.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.51 -0.15 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Zacks News
Monster Beverage's (MNST) Growth Strategies Progress Well
by Zacks Equity Research
Monster Beverage (MNST) has been gaining from strength in its energy drinks category and product innovations.
COTY Benefits From Solid Beauty Trends and Partnerships
by Zacks Equity Research
Coty (COTY) is well-positioned to capitalize on favorable beauty trends. The company is making several strategic partnerships to enhance its brand portfolio.
Monster Beverage (MNST) Q4 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) posts soft fourth-quarter 2023 results, wherein the top and bottom lines miss the Zacks Consensus Estimate.
Inter Parfums (IPAR) Lags Q4 Earnings Estimate, Sales Rise Y/Y
by Zacks Equity Research
Inter Parfums (IPAR) reports fourth-quarter 2023 performance, with earnings declining year over year. Net sales increase on continued demand for its brands.
Inter Parfums (IPAR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Inter Parfums (IPAR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Freshpet (FRPT) Q4 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Freshpet's (FRPT) impressive quarterly results, along with strategic improvements and an optimistic 2024 outlook, indicate a bright future for the company.
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
by Zacks Equity Research
HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte are part of the Zacks top Analyst Blog.
Celsius Holdings (CELH) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Celsius Holdings' (CELH) fourth-quarter results are likely to reflect gains from effective distribution strategies, strong market penetration, product innovation and operational excellence.
The Zacks Analyst Blog Highlights Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage
by Zacks Equity Research
Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage are part of the Zacks top Analyst Blog.
What Will Global Partners' (GLP) Q4 Earnings Unveil?
by Zacks Equity Research
Global Partners LP (GLP) beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed in the other two.
Hormel Foods (HRL) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Hormel Foods' (HRL) fiscal first-quarter results are likely to reflect challenges in the International segment, while capacity expansion endeavors bode well.
Pure Storage (PSTG) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Pure Storage's (PSTG) fourth-quarter performance is likely to have been affected by a delay in the fulfillment of a $41 million non-cancelable product order until next year with a Telco customer.
5 Stocks to Buy That Are Poised to Beat on Earnings This Week
by Nalak Das
We have narrowed our search to five stocks that are poised to beat on earnings this week. These are: HEi, CEG, IPAR, APLS, PCVX.
5 Consumer Staple Stocks to Buy Amid Ongoing Market Volatility
by Ritujay Ghosh
Consumer staple stocks like Colgate-Palmolive Company (CL), Church & Dwight Co., Inc. (CHD), Inter Parfums, Inc. (IPAR), Lamb Weston Holdings, Inc. (LW) and Molson Coors Beverage Company (TAP) are a safe bet amid the ongoing market volatility.
Can AB InBev (BUD) Beat Earnings in Q4 Amid Elevated Costs?
by Zacks Equity Research
AB InBev's (BUD) Q4 results are expected to reflect gains from pricing actions, ongoing premiumization, a strong brand portfolio and revenue management initiatives amid high costs.
Keurig Dr Pepper (KDP) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Keurig Dr Pepper's (KDP) fourth-quarter 2023 results benefit from continued brand strength and significant pricing.
The J.M. Smucker (SJM) Q3 Earnings Coming Up: Factors to Note
by Zacks Equity Research
The J.M. Smucker's (SJM) fiscal third-quarter results are likely to reflect gains from pricing and brand strength, along with the impacts of the Hostess Brands buyout.
Earnings Preview: Olaplex Holdings, Inc. (OLPX) Q4 Earnings Expected to Decline
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Monster Beverage (MNST) Looks Poised for Earnings Beat in Q4
by Zacks Equity Research
Monster Beverage (MNST) Q4 results are expected to reflect gains from the strong energy drinks category, product launches, innovation, pricing actions and the easing of supply-chain headwinds.
Can Boston Beer (SAM) Beat Q4 Earnings Amid Soft Shipments?
by Zacks Equity Research
Boston Beer (SAM) Q4 results are expected to reflect gains from robust trends for its twisted tea brand, premiumization, innovation and growth of its Beyond Beer category.
Zacks Industry Outlook Highlights Estee Lauder, Coty, Inter Parfums, and Helen of Troy
by Zacks Equity Research
Estee Lauder, Coty, Inter Parfums, and Helen of Troy have been highlighted in this Industry Outlook article.
International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.
Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
by Zacks Equity Research
Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.
Things to Note Ahead of Inter Parfums' (IPAR) Q4 Earnings
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2023 performance will likely reflect the adverse impact of rising advertising and promotion costs. Nevertheless, a solid brand portfolio is likely to aid growth.
4 Cosmetics Stocks Worth Watching on Robust Industry Trends
by Ansuiya Mohta
The Zacks Cosmetics industry companies are benefiting from a burgeoning demand for skincare and personal care products. Focus on innovations is propelling The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).